Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Truncated Glioma-Associated Oncogene Homolog 1 (tGLI1) Mediates Mesenchymal Glioblastoma via Transcriptional Activation of CD44

20 Feb 2018

Abstract excerpt

Abstract The molecular pathways driving mesenchymal glioblastoma (GBM) are still not well understood. We report here that truncated glioma-associated oncogene homolog 1 (tGLI1) is a tumor-specific transcription factor that facilitates GBM growth, is enriched in the mesenchymal subtype of GBM and glioma stem cells (GSC), and promotes mesenchymal GSC by upregulating transcription of CD44. In an orthotopic GBM...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chromatin Remodeling and Cancer
Share to Glioma Diagnosis and Treatment
Share to Hedgehog Signaling Pathway Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29463580
DOI: 10.1158/0008-5472.can-17-2933

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Truncated Glioma-Associated Oncogene Homolog 1 (tGLI1) Mediates Mesenchymal Glioblastoma via Transcriptional Activation of CD44PMID 29463580Read ↗

Comprehensive understanding of glioblastoma molecular phenotypes: classification, characteristics, and transition.Semantic proximity Read ↗

Cancer stem cells in glioblastoma—molecular signaling and therapeutic targetingSemantic proximity Read ↗

Gremlin1 promotes carcinogenesis of glioma in vitroSemantic proximity Read ↗

Transcription factors ASCL1 and OLIG2 drive glioblastoma initiation and co-regulate tumor cell types and migration.Semantic proximity Read ↗

Differentiated glioblastoma cells accelerate tumor progression by shaping the tumor microenvironment via CCN1-mediated macrophage infiltrationSemantic proximity Read ↗

Augmented expression of RUNX1 deregulates the global gene expression of U87 glioblastoma multiforme cells and inhibits tumor growth in miceSemantic proximity Read ↗

Transcriptional regulatory networks of tumor-associated macrophages that drive malignancy in mesenchymal glioblastoma.Semantic proximity Read ↗

GALNT2 sustains glioma stem cells by promoting CD44 expressionSemantic proximity Read ↗

Identification of PDLIM1 as a glioblastoma stem cell marker driving tumorigenesis and chemoresistanceSemantic proximity Read ↗

Genomics and Prognosis Analysis of Epithelial-Mesenchymal Transition in GliomaSemantic proximity Read ↗

The significance of epithelial–mesenchymal transition (EMT) in the initiation, plasticity, and treatment of glioblastomaSemantic proximity Read ↗

Distinct Myeloid Derived Suppressor Cell Populations Promote Tumor Aggression in GlioblastomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.